F Mahfoud, O Vonend, H Bruck, W Clasen, S Eckert, B Frye, H Haller, M Hausberg, U C Hoppe, J Hoyer, K Hahn, T Keller, B K Krämer, R Kreutz, S A Potthoff, H Reinecke, R Schmieder, V Schwenger, U Kintscher, M Böhm, L C Rump et al.
This commentary summarizes the expert consensus and recommendations of the working group 'Herz und Niere' of the German Society of Cardiology (DGK), the German Society of Nephrology (DGfN) and the German Hypertension League (DHL) on renal denervation for antihypertensive treatment. Renal denervation is a new, interventional approach to selectively denervate renal afferent and efferent sympathetic fibers. Renal denervation has been demonstrated to reduce office systolic and diastolic blood pressure in patients with resistant hypertension, defined as systolic office blood pressure ≥ 160 mm Hg and ≥ 150 mm Hg in patients with diabetes type 2, which should currently be used as blood pressure thresholds for undergoing the procedure...
November 2011: Deutsche Medizinische Wochenschrift